Carboplatin and etoposide chemotherapy in extrapulmonary poorly differentiated neuroendocrine carcinomas

被引：0
|
作者：
Galdy, S. [1 ]
Aurilio, G. [1 ]
Radice, D. [1 ]
Spada, F. [1 ]
Cella, C. A. [1 ]
Frezza, A. M. [1 ]
Nole, F. [1 ]
Fazio, N. [1 ]
机构：
[1] Ist Europeo Oncol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
R20
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas
    Strosberg, Jonathan R.
    Coppola, Domenico
    Klimstra, David S.
    Phan, Alexandria T.
    Kulke, Matthew H.
    Wiseman, Gregory A.
    Kvols, Larry K.
    PANCREAS, 2010, 39 (06) : 799 - 800
  • [22] ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas
    Robin Schmitz
    Dimitrios Moris
    John H. Strickler
    Dan G. Blazer
    Annals of Surgical Oncology, 2020, 27 : 804 - 805
  • [23] ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas
    Schmitz, Robin
    Moris, Dimitrios
    Strickler, John H.
    Blazer, Dan G., III
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 804 - 805
  • [24] NEUROENDOCRINE FEATURES IN POORLY DIFFERENTIATED AND UNDIFFERENTIATED CARCINOMAS OF THE CERVIX
    BARRETT, RJ
    DAVOS, I
    LEUCHTER, RS
    LAGASSE, LD
    CANCER, 1987, 60 (09) : 2325 - 2330
  • [25] Efficacy of chemotherapy for elderly patients with extrapulmonary neuroendocrine carcinomas
    Funasaka, C.
    Yasushi, O.
    Kanemasa, Y.
    Shimoyama, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] Poorly Differentiated Neuroendocrine Carcinomas of the Colon: A Clinicopathological Study
    Boeck, I
    Weihe, E.
    Krieg, A.
    Gabbert, H. E.
    Raffel, A.
    Krausch, M.
    Kraemling, H. J.
    Neuhaus, H.
    Anlauf, M.
    NEUROENDOCRINOLOGY, 2018, 106 : 137 - 137
  • [27] Efficacy of FOLFIRI as a second -line in extrapulmonary poorly differentiated neuroendocrine carcinoma
    Fabregat-Franco, Carles
    Munoz, M. Nieva
    Martin, F. Perez
    Ruffinelli, J.
    Vivas, C. Santos
    Sanchez, C.
    Salazar, R.
    Teule, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
    Apostolidis, Leonidas
    Bergmann, Frank
    Jaeger, Dirk
    Winkler, Eva Caroline
    CANCER MEDICINE, 2016, 5 (09): : 2261 - 2267
  • [29] RETROSPECTIVE ANALYSIS OF CHEMOTHERAPY FOR EXTRAPULMONARY NEUROENDOCRINE CARCINOMAS (EPNEC)
    Taguchi, Jun
    Kinoshita, Ichiro
    Fukuda, Naoki
    Ariga, Shin
    Goda, Tomohiro
    Honma, Rio
    Amano, Toraji
    Takeuchi, Satoshi
    Shimizu, Yasushi
    Akita, Hirotoshi
    ANNALS OF ONCOLOGY, 2014, 25
  • [30] Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis
    Puliafito, Ivana
    Chillari, Federico
    Russo, Alessandro
    Cantale, Ornella
    Sciacca, Dorotea
    Castorina, Luigi
    Colarossi, Cristina
    Franchina, Tindara
    Vitale, Maria Paola
    Ricciardi, Giuseppina Rosaria Rita
    Adamo, Vincenzo
    Esposito, Francesca
    Giuffrida, Dario
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345